When ApoA1 enters the brain, it has been found to colocalize with Amyloid beta (Aβ) plaques in the cortex in patients with AD [102], thus suggesting that ApoA1 might affect amyloid precursor protein (APP) cleavage, Aβ aggregation, and Aβ clearance. This evidence concerns the gene APP and Alzheimer disease.